research
71 articles tagged
MIT functions as the upstream catalyst for global robotics and autonomy, generating companies, talent, and governance frameworks at scale no commercial firm can replicate.
Humanoid (SKL Robotics) has one verified PoC with SAP but zero disclosed funding, leadership, or commercial deployments—a critical gap in the humanoid robotics market.
Medical robotics market projected to reach $74.07B by 2034, but growth benefits established players with FDA clearance over new entrants facing regulatory barriers.
Positronic Robotics lacks documented products, certifications, or deployments despite launching a benchmarking tool, raising red flags for investors and analysts.
Positronic Robotics' PhAIL benchmark launch is a credibility-building exercise, not evidence of commercial readiness in industrial, personal care, or medical robotics segments.
Humanoid (SKL Robotics) has only one verified proof-of-concept with SAP/Martur Fompak, leaving it far behind capitalized competitors like Figure AI and Agility Robotics in commercial validation.
Icarus Robotics partners with Voyager to test its free-flying Joy robot aboard the ISS in 2027, targeting microgravity cargo logistics and crew time savings.
Icarus Robotics secures ISS access via Voyager partnership to test free-flying manipulation robot Joy, with 2027 on-orbit demo targeting proprietary microgravity dataset collection.
Greystones Group lacks foundational corporate identifiers and verifiable product evidence despite an Army Research Lab CRADA, raising questions about its credibility in defense autonomy.
JPL's 40 active missions and 162-mission portfolio represent an unmatched autonomy validation record in extreme environments that commercial competitors cannot replicate.